JSC "Grindeks" informs that in the 1999 by introducing new products and

by  reorienting markets JSC "Grindeks" is planning to increase turnover

up to LVL 13

million and to get profit in the amount of LVL 500 000.

In  the 1998 JSC "Grindeks" invested USD 1,1 million in the development

of  the company. This year JSC "Grindeks" is planning to invest USD 400

000  in  the  development  of  production  units  and  licensing of new

products.

At  present  JSC "Grindeks" is the largest medicine producer for market

of  Latvia  their  market  share  is 5 %. JSC "Grindeks" is planning to

increase  their market share up to 10-11 % , at the same time orienting

to the other markets.

Management  of  JSC "Grindeks" is implementing new development strategy

by  establishing  holdingcompany. Starting 1999 company is distributing

all Tallinn Pharmaceutical Co produce in the Baltic, Europe, Russia and

other regions.